Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Using direct infusion mass spectrometry for serum metabolomics in Alzheimer’s disease
Raúl González‐Domínguez, Tamara García‐Barrera, José Luis Gómez‐Ariza
Analytical and Bioanalytical Chemistry (2014) Vol. 406, Iss. 28, pp. 7137-7148
Closed Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease
Huaqi Su, Yepy H. Rustam, Colin L. Masters, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 7
Open Access | Times Cited: 111
Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
Medi Kori, Büşra Aydın, Semra Ünal, et al.
OMICS A Journal of Integrative Biology (2016) Vol. 20, Iss. 11, pp. 645-661
Closed Access | Times Cited: 128
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
Massimo S. Fiandaca, Xiaogang Zhong, Amrita K. Cheema, et al.
Frontiers in Neurology (2015) Vol. 6
Open Access | Times Cited: 109
Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4−/−: A double-blind, randomized, placebo-controlled crossover trial
Qing Xu, Yong Zhang, Xinsheng Zhang, et al.
Clinical Nutrition (2019) Vol. 39, Iss. 7, pp. 2092-2105
Closed Access | Times Cited: 103
Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites
Takayuki Teruya, Yung-Ju Chen, Yasuhide Fukuji, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 37
Open Access | Times Cited: 78
Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
Nishit Pathak, Sunil Kumar Vimal, Ishi Tandon, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 67-104
Closed Access | Times Cited: 64
Apolipoprotein E and sex modulate fatty acid metabolism in a prospective observational study of cognitive decline
Raúl González‐Domínguez, Pol Castellano‐Escuder, Sophie Lefèvre‐Arbogast, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Simone Lista, Raúl González‐Domínguez, Susana López‐Ortiz, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101987-101987
Closed Access | Times Cited: 33
Metabolomics-based screening of salivary biomarkers for early diagnosis of Alzheimer's disease
Qun Liang, Han Liu, Tianyu Zhang, et al.
RSC Advances (2015) Vol. 5, Iss. 116, pp. 96074-96079
Closed Access | Times Cited: 83
Direct Infusion Mass Spectrometry for Metabolomic Phenotyping of Diseases
Raúl González‐Domínguez, Ana Sayago, Ángeles Fernández-Recamales
Bioanalysis (2016) Vol. 9, Iss. 1, pp. 131-148
Closed Access | Times Cited: 82
Metabolomics in Alzheimer’s disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology
Raúl González‐Domínguez, Ana Sayago, Ángeles Fernández-Recamales
Journal of Chromatography B (2017) Vol. 1071, pp. 75-92
Open Access | Times Cited: 68
A Metabolomics Approach to Pharmacotherapy Personalization
Elena E. Balashova, Dmitry L. Maslov, Petr G. Lokhov
Journal of Personalized Medicine (2018) Vol. 8, Iss. 3, pp. 28-28
Open Access | Times Cited: 67
Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform
Belén Callejón‐Leblic, Tamara García‐Barrera, Jesús Grávalos-Guzmán, et al.
Journal of Proteomics (2016) Vol. 145, pp. 197-206
Open Access | Times Cited: 66
Direct Infusion Based Metabolomics Identifies Metabolic Disease in Patients’ Dried Blood Spots and Plasma
Hanneke A. Haijes, Marcel Willemsen, Maria van der Ham, et al.
Metabolites (2019) Vol. 9, Iss. 1, pp. 12-12
Open Access | Times Cited: 66
Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia
Gaetano Corso, Adriana Cristofano, Nadia Sapere, et al.
Dementia and Geriatric Cognitive Disorders Extra (2017) Vol. 7, Iss. 1, pp. 143-159
Open Access | Times Cited: 62
Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker
Carmen Peña‐Bautista, Marta Roca, David Hervás, et al.
Journal of Proteomics (2019) Vol. 200, pp. 144-152
Closed Access | Times Cited: 62
Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease
Ling Hao, Jingxin Wang, David Page, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes
Mariusz G. Fleszar, Jerzy Wiśniewski, Marzena Zboch, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 58
Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
Zhang Xue-ju, Wei-Wei Liu, Jie Zan, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease
Yunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114128-114128
Open Access | Times Cited: 6
Mixed-mode cationic exchange paper combined with direct infusion mass spectrometry, a sustainable approach to determine opioids in biosamples
Ana M. Pedraza-Soto, Rafael Lucena, Soledad Cárdenas
Sustainable Chemistry and Pharmacy (2024) Vol. 41, pp. 101723-101723
Open Access | Times Cited: 6
The role of metabolomics in determination of new dietary biomarkers
Aoife O’Gorman, Lorraine Brennan
Proceedings of The Nutrition Society (2017) Vol. 76, Iss. 3, pp. 295-302
Open Access | Times Cited: 60
Discovery of serum metabolites for diagnosis of progression of mild cognitive impairment to Alzheimer's disease using an optimized metabolomics method
Qun Liang, Han Liu, Tianyu Zhang, et al.
RSC Advances (2016) Vol. 6, Iss. 5, pp. 3586-3591
Closed Access | Times Cited: 59
Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease
Raúl González‐Domínguez, Tamara García‐Barrera, Javier Vitórica, et al.
Journal of Pharmaceutical and Biomedical Analysis (2015) Vol. 107, pp. 378-385
Open Access | Times Cited: 54
Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment: A Pilot Study
Ali Yılmaz, Zafer Ugur, Halil Bişğin, et al.
Metabolites (2020) Vol. 10, Iss. 9, pp. 357-357
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top